Phase III XELOX trial in metastatic colorectal cancer meets primary endpoints

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2006年 / 20卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1871 / 1872
页数：2
相关论文
共 50 条
  • [41] A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancer
    Zonder, JA
    Shields, AF
    Zalupski, M
    Chaplen, R
    Heilbrun, LK
    Arlauskas, P
    Philip, PA
    CLINICAL CANCER RESEARCH, 2001, 7 (01) : 38 - 42
  • [42] Erratum: A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer
    O A Khan
    M Ranson
    M Michael
    I Olver
    N C Levitt
    P Mortimer
    A J Watson
    G P Margison
    R Midgley
    M R Middleton
    British Journal of Cancer, 2009, 101 : 550 - 550
  • [43] Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer
    Meadows, SM
    Mulkerin, D
    Berlin, J
    Bailey, H
    Kolesar, J
    Warren, D
    Thomas, JP
    JOURNAL OF GASTROINTESTINAL CANCER, 2002, 32 (2-3) : 125 - 128
  • [44] Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer
    Sherry Morgan Meadows
    Daniel Mulkerin
    Jordan Berlin
    Howard Bailey
    Jill Kolesar
    Deb Warren
    James P. Thomas
    International Journal of Gastrointestinal Cancer, 2002, 32 : 125 - 128
  • [45] First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study
    Diaz-Rubio, Eduardo
    Gomez-Espana, Auxiliadora
    Massuti, Bartomeu
    Sastre, Javier
    Abad, Albert
    Valladares, Manuel
    Rivera, Fernando
    Safont, Maria J.
    Martinez de Prado, Purificacion
    Gallen, Manuel
    Gonzalez, Encarnacion
    Marcuello, Eugenio
    Benavides, Manuel
    Fernandez-Martos, Carlos
    Losa, Ferran
    Escudero, Pilar
    Arrivi, Antonio
    Cervantes, Andres
    Duenas, Rosario
    Lopez-Ladron, Amelia
    Lacasta, Adelaida
    Llanos, Marta
    Tabernero, Jose M.
    Anton, Antonio
    Aranda, Enrique
    ONCOLOGIST, 2012, 17 (01): : 15 - 25
  • [46] Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer
    Karasic, Thomas B.
    Brown, Timothy J.
    Schneider, Charles
    Teitelbaum, Ursina R.
    Reiss, Kim A.
    Mitchell, Tara C.
    Massa, Ryan C.
    O'Hara, Mark H.
    DiCicco, Lisa
    Garcia-Marcano, Luis
    Amaravadi, Ravi K.
    O'Dwyer, Peter J.
    ONCOLOGIST, 2022, 27 (09): : 716 - +
  • [47] Second-line XELOX or FOLFOX-4 for metastatic colorectal cancer
    Teitelbaum, Ursina R.
    Haller, Daniel G.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (05) : 250 - 251
  • [48] Second-line XELOX or FOLFOX-4 for metastatic colorectal cancer
    Ursina R. Teitelbaum
    Daniel G. Haller
    Nature Reviews Clinical Oncology, 2009, 6 : 250 - 251
  • [49] Metastatic colorectal cancer to a primary thyroid cancer
    Cherk, Martin H.
    Moore, Maggie
    Serpell, Jonathan
    Swain, Sarah
    Topliss, Duncan J.
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2008, 6 (1)
  • [50] Metastatic colorectal cancer to a primary thyroid cancer
    Martin H Cherk
    Maggie Moore
    Jonathan Serpell
    Sarah Swain
    Duncan J Topliss
    World Journal of Surgical Oncology, 6
12345